Association of Germline BRCA2 Mutations With the Risk of Pediatric or Adolescent Non–Hodgkin Lymphoma
Authors:
Open Access
- 1 September 2019
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 5 (9) , 1362-1364
Abstract
In a previous report from the St Jude Lifetime (SJLIFE) study, BRCA2 (GenBank U43746 .1) was the third most frequently mutated gene (14 occurrences) among 3006 survivors of childhood cancer, with the highest number observed among survivors of lymphoma (7 [1.2%] of 586).1 To further investigate BRCA2 as a potential predisposition gene for pediatric or adolescent lymphoma, we analyzed 794 additional survivors of lymphoma from the SJLIFE study2 and Childhood Cancer Survivor Study3 cohorts, using whole-genome sequencing data.Keywords
This publication has 6 references indexed in Scilit:
- Genetic Risk for Subsequent Neoplasms Among Long-Term Survivors of Childhood CancerJournal of Clinical Oncology, 2018
- Approach for Classification and Severity Grading of Long-term and Late-Onset Health Events among Childhood Cancer Survivors in the St. Jude Lifetime CohortCancer Epidemiology, Biomarkers & Prevention, 2017
- Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and GenomicsGenetics in Medicine, 2017
- Germline Mutations in Predisposition Genes in Pediatric CancerNew England Journal of Medicine, 2015
- Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutationsFamilial Cancer, 2011
- The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention ResearchJournal of Clinical Oncology, 2009